0001193125-20-014283.txt : 20200124 0001193125-20-014283.hdr.sgml : 20200124 20200124164809 ACCESSION NUMBER: 0001193125-20-014283 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20200123 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20200124 DATE AS OF CHANGE: 20200124 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Horizon Therapeutics Public Ltd Co CENTRAL INDEX KEY: 0001492426 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35238 FILM NUMBER: 20546078 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE, 1ST FLOOR STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 BUSINESS PHONE: 011-353-1-772-2100 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE, 1ST FLOOR STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 FORMER COMPANY: FORMER CONFORMED NAME: Horizon Pharma plc DATE OF NAME CHANGE: 20140919 FORMER COMPANY: FORMER CONFORMED NAME: HORIZON PHARMA, INC. DATE OF NAME CHANGE: 20100520 8-K 1 d863925d8k.htm 8-K 8-K
Horizon Therapeutics Public Ltd Co 00-0000000 772-2100 false 0001492426 0001492426 2020-01-23 2020-01-23

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 23, 2020

 

Horizon Therapeutics Public Limited Company

(Exact name of registrant as specified in its charter)

 

Ireland

  

001-35238

  

Not Applicable

(State or other jurisdiction

of incorporation)

  

(Commission

File No.)

  

(IRS Employer

Identification No.)

Connaught House, 1st Floor, 1 Burlington Road, Dublin 4, D04 C5Y6, Ireland

(Address of principal executive offices)

Registrant’s telephone number, including area code: 011-353-1-772-2100

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:    

Title of each class

  

Trading

Symbol(s)

  

Name of each exchange

on which registered

Ordinary shares, nominal value $0.0001 per share

  

HZNP

  

The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Effective January 23, 2020, Shao-Lee Lin, M.D., Ph.D. is no longer employed with the Company. Pursuant to Dr. Lin’s employment agreement, upon execution and effectiveness of a release of claims, she will be entitled to certain severance benefits as described in the Company’s proxy statement filed on April 8, 2019.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: January 24, 2020

 

 

HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY

             

 

 

By:

 

/s/ Paul W. Hoelscher

 

 

 

Paul W. Hoelscher

 

 

 

Executive Vice President, Chief Financial Officer

EX-101.SCH 2 hznp-20200123.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 3 hznp-20200123_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Entity Registrant Name Entity Registrant Name Entity Tax Identification Number Entity Tax Identification Number Local Phone Number Local Phone Number Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, Address Line Three Entity Address, City or Town Entity Address, City or Town Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Address, Country Entity Address, Country City Area Code City Area Code Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company EX-101.PRE 4 hznp-20200123_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 7 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.3.a.u2 html 1 97 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.horizonoharma.com//20200123/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d863925d8k.htm hznp-20200123.xsd hznp-20200123_lab.xml hznp-20200123_pre.xml http://xbrl.sec.gov/dei/2019-01-31 true false XML 8 d863925d8k_htm.xml IDEA: XBRL DOCUMENT 0001492426 2020-01-23 2020-01-23 Horizon Therapeutics Public Ltd Co 00-0000000 772-2100 false 0001492426 8-K 2020-01-23 L2 001-35238 Connaught House 1st Floor 1 Burlington Road Dublin 4 D04 C5Y6 IE 011-353-1 false false false false Ordinary shares, nominal value $0.0001 per share HZNP NASDAQ false XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } JSON 11 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d863925d8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "d863925d8k.htm" ] }, "labelLink": { "local": [ "hznp-20200123_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "hznp-20200123_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "hznp-20200123.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd" ] } }, "elementCount": 25, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 5, "total": 5 }, "keyCustom": 0, "keyStandard": 97, "memberCustom": 0, "memberStandard": 0, "nsprefix": "hznp", "nsuri": "http://www.horizonoharma.com/20200123", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "div", "body", "html" ], "baseRef": "d863925d8k.htm", "contextRef": "duration_2020-01-23_to_2020-01-23", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://www.horizonoharma.com//20200123/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "div", "body", "html" ], "baseRef": "d863925d8k.htm", "contextRef": "duration_2020-01-23_to_2020-01-23", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20200123/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20200123/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20200123/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20200123/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20200123/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20200123/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three", "terseLabel": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20200123/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20200123/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country", "terseLabel": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20200123/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20200123/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20200123/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20200123/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20200123/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20200123/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20200123/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20200123/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20200123/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20200123/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20200123/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title", "terseLabel": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20200123/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20200123/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20200123/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20200123/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20200123/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } EXCEL 12 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Document and Entity Information
Jan. 23, 2020
Cover [Abstract]  
Entity Registrant Name Horizon Therapeutics Public Ltd Co
Entity Tax Identification Number 00-0000000
Local Phone Number 772-2100
Amendment Flag false
Entity Central Index Key 0001492426
Document Type 8-K
Document Period End Date Jan. 23, 2020
Entity Incorporation State Country Code L2
Entity File Number 001-35238
Entity Address, Address Line One Connaught House
Entity Address, Address Line Two 1st Floor
Entity Address, Address Line Three 1 Burlington Road
Entity Address, City or Town Dublin 4
Entity Address, Postal Zip Code D04 C5Y6
Entity Address, Country IE
City Area Code 011-353-1
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Ordinary shares, nominal value $0.0001 per share
Trading Symbol HZNP
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
ZIP 14 0001193125-20-014283-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-20-014283-xbrl.zip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end